AcroMeta Group Limited Financial Analysis: Net Profit Growth of S\$1.9 Million in FY24

Business Description

AcroMeta Group Limited is primarily an investment holding company listed on the Catalist of the Singapore Exchange. The company operates through two main business segments: Maintenance and Co-working Laboratory Space. The Maintenance segment provides services for facilities and equipment in controlled environments, while the co-working laboratory space is managed through a 70% owned subsidiary, Life Science Incubator Holdings Pte Ltd, with locations in Singapore.

Industry Position

The company operates within the specialized maintenance and co-working laboratory space sectors. The report does not provide specific details on competitors or market share, but it indicates that the company faces challenges due to inflationary pressures and macroeconomic uncertainties.

Revenue Streams and Customer Base

The company’s revenue is derived from maintenance services and co-working laboratory spaces. The maintenance segment provides recurring revenue, adding stability. The revenue from the maintenance business grew by 29% in FY24, whereas the discontinued operations from EPC and co-working laboratory segments contributed significantly to the total revenue of S\$33.8 million for the year.

Financial Statement Analysis

Income Statement

The company reported a net profit attributable to owners of S\$1.9 million in FY24, a significant improvement from a net loss of S\$7.0 million in the previous year. This profit was largely due to gains from discontinued operations, including a waiver of loans and disposal of subsidiaries.

Balance Sheet

Total assets decreased from S\$34.3 million in FY23 to S\$16.2 million in FY24, primarily due to asset disposals. Current liabilities also saw a reduction, aligning with the company’s strategic disposals. The net asset value per share increased from 1.12 cents to 1.99 cents.

Cash Flow Statement

The company’s cash and cash equivalents decreased due to net cash used in operations and financing activities. However, investing activities provided some cash inflow due to proceeds from asset disposals.

Dividend Information

No dividend has been declared or recommended for the current reporting period due to operating losses.

Key Findings

Strengths: Improved profitability in FY24, strategic disposals to streamline operations, and stable recurring revenue from the maintenance segment.

Risks: Reduced asset base, dependence on maintenance segment for stability, and macroeconomic challenges impacting operational efficiency.

Special Activities

The company is disposing of its subsidiary, Life Science Incubator Holdings, to improve financial positioning and focus on core operations. Additionally, it incorporated a new subsidiary, AcroMeta Lifestyle Pte. Ltd., aiming to expand into consumer electronics.

Recommendations

For Current Investors: Consider holding the stock due to recent profitability improvements. However, keep an eye on macroeconomic factors that might impact future performance.

For Potential Investors: Approach with caution. Evaluate the company’s ability to sustain positive cash flows amidst economic uncertainties before investing.

Disclaimer

This recommendation is based solely on the information provided in the financial report and does not constitute financial advice. Investors should perform their own due diligence and consider consulting with a financial advisor.

View AcroMeta Historical chart here